ArticleTheranostics2020

Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies.

Levin Schriewer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.